甲状腺癌核分子影像的最新进展。
Recent Development of Nuclear Molecular Imaging in Thyroid Cancer.
机构信息
Department of Nuclear Medicine, Chongqing Three Gorges Central Hospital, Wanzhou 404000, China.
Clinical Test Center, Chongqing Three Gorges Central Hospital, Wanzhou 404000, China.
出版信息
Biomed Res Int. 2018 May 21;2018:2149532. doi: 10.1155/2018/2149532. eCollection 2018.
Abstract
Therapies targeting specific tumor pathways are easy to enter the clinic. To monitor molecular changes, cellular processes, and tumor microenvironment, molecular imaging is becoming the key technology for personalized medicine because of its high efficacy and low side effects. Thyroid cancer is the most common endocrine malignancy, and its theranostic radioiodine has been widely used to diagnose or treat differentiated thyroid cancer. This article summarizes recent development of molecular imaging in thyroid cancer, which may accelerate the development of personalized thyroid cancer therapy.
摘要
针对特定肿瘤途径的治疗方法很容易进入临床。为了监测分子变化、细胞过程和肿瘤微环境，分子成像正成为个性化医疗的关键技术，因为它具有高效和低副作用的特点。甲状腺癌是最常见的内分泌恶性肿瘤，其放射性碘治疗已广泛用于诊断或治疗分化型甲状腺癌。本文总结了甲状腺癌分子成像的最新进展，这可能会加速个性化甲状腺癌治疗的发展。
相似文献
1
Recent Development of Nuclear Molecular Imaging in Thyroid Cancer.甲状腺癌核分子影像的最新进展。
Biomed Res Int. 2018 May 21;2018:2149532. doi: 10.1155/2018/2149532. eCollection 2018.
2
Personalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated Thyroid Cancer.基于诊疗一体化放射性碘分子成像的分化型甲状腺癌个性化医学
Biomed Res Int. 2016;2016:1680464. doi: 10.1155/2016/1680464. Epub 2016 Apr 28.
3
Lesionalized therapy beyond personalized therapy in cancer management.癌症管理中超越个性化治疗的病灶靶向治疗。
J Korean Med Sci. 2014 Oct;29(10):1331-2. doi: 10.3346/jkms.2014.29.10.1331.
4
Updated Review of Nuclear Molecular Imaging of Thyroid Cancers.甲状腺癌核分子影像的最新综述
Endocr Pract. 2021 May;27(5):494-502. doi: 10.1016/j.eprac.2020.10.001. Epub 2020 Dec 14.
5
Molecular imaging of advanced thyroid cancer: iodinated radiotracers and beyond.先进甲状腺癌的分子影像：碘放射性示踪剂及其他。
Med Oncol. 2017 Oct 30;34(12):189. doi: 10.1007/s12032-017-1051-x.
6
Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.甲状腺球蛋白、放射性碘成像及正电子发射断层扫描在甲状腺癌评估中的各自作用。
Semin Nucl Med. 2006 Jul;36(3):194-205. doi: 10.1053/j.semnuclmed.2006.03.002.
7
Selected Controversies of Radioiodine Imaging and Therapy in Differentiated Thyroid Cancer.分化型甲状腺癌放射性碘显像与治疗的若干争议
Endocrinol Metab Clin North Am. 2017 Sep;46(3):783-793. doi: 10.1016/j.ecl.2017.04.007. Epub 2017 Jun 29.
8
[Theranostics and differentiated thyroid cancer].[治疗诊断学与分化型甲状腺癌]
Magy Onkol. 2020 Jun 10;64(2):112-117. Epub 2020 Feb 2.
9
Designing and Developing PET-Based Precision Model in Thyroid Carcinoma: The Potential Avenues for a Personalized Clinical Care.设计与开发基于正电子发射断层扫描（PET）的甲状腺癌精准模型：个性化临床护理的潜在途径
PET Clin. 2017 Jan;12(1):27-37. doi: 10.1016/j.cpet.2016.08.007. Epub 2016 Sep 23.
10
Theranostic role of radiolabelled RGD peptide in the treatment of radioiodine-resistant thyroid cancer: A novel agent.放射性标记的RGD肽在放射性碘难治性甲状腺癌治疗中的诊疗作用：一种新型药物。
Indian J Med Res. 2020 Nov;152(Suppl 1):S258-S259. doi: 10.4103/ijmr.IJMR_2377_19.
引用本文的文献
1
Correlation between socioeconomic indices and epidemiological indices of thyroid cancer from 1990 to 2019 year: a global ecologic study.1990 年至 2019 年甲状腺癌的社会经济指标与流行病学指标的相关性：一项全球生态学研究。
BMC Cancer. 2024 Apr 15;24(1):467. doi: 10.1186/s12885-024-12176-y.
2
An Artificial Intelligence System for Optimizing Radioactive Iodine Therapy Dosimetry.一种用于优化放射性碘治疗剂量测定的人工智能系统。
J Clin Med. 2023 Dec 25;13(1):117. doi: 10.3390/jcm13010117.
3
Nuclear Imaging Modalities in the Diagnosis and Management of Thyroid Cancer.核成像技术在甲状腺癌诊断与管理中的应用
Curr Mol Med. 2024;24(9):1091-1096. doi: 10.2174/1566524023666230915103723.
4
Towards an era of precise diagnosis and treatment: Role of novel molecular modification-based imaging and therapy for dedifferentiated thyroid cancer.迈向精准诊断与治疗的时代：新型分子修饰基成像与治疗在去分化型甲状腺癌中的作用。
Front Endocrinol (Lausanne). 2022 Sep 8;13:980582. doi: 10.3389/fendo.2022.980582. eCollection 2022.
5
ImmunoPET: Antibody-Based PET Imaging in Solid Tumors.免疫正电子发射断层显像：实体瘤中基于抗体的正电子发射断层显像成像
Front Med (Lausanne). 2022 Jun 28;9:916693. doi: 10.3389/fmed.2022.916693. eCollection 2022.
6
Personalized Diagnosis in Differentiated Thyroid Cancers by Molecular and Functional Imaging Biomarkers: Present and Future.通过分子和功能成像生物标志物实现分化型甲状腺癌的个性化诊断：现状与未来
Diagnostics (Basel). 2022 Apr 10;12(4):944. doi: 10.3390/diagnostics12040944.
7
Cholecystokinin-2 Receptor Targeting with Radiolabeled Peptides: Current Status and Future Directions.胆囊收缩素-2 受体放射性肽靶向：现状与未来方向。
Curr Med Chem. 2020;27(41):7112-7132. doi: 10.2174/0929867327666200625143035.
8
Molecular Imaging of Galectin-1 Expression as a Biomarker of Papillary Thyroid Cancer by Using Peptide-Functionalized Imaging Probes.使用肽功能化成像探针将半乳糖凝集素-1表达作为甲状腺乳头状癌生物标志物的分子成像
Biology (Basel). 2020 Mar 14;9(3):53. doi: 10.3390/biology9030053.
本文引用的文献
1
Hybrid SPECT/CT Imaging in the Management of Differentiated Thyroid Carcinoma.混合单光子发射计算机断层扫描/计算机断层扫描成像在分化型甲状腺癌管理中的应用
Asian Pac J Cancer Prev. 2018 Feb 26;19(2):303-308. doi: 10.22034/APJCP.2018.19.2.303.
2
Molecular imaging of platelet-derived growth factor receptor-alpha (PDGFRα) in papillary thyroid cancer using immuno-PET.采用免疫 PET 对甲状腺乳头癌中血小板衍生生长因子受体-α（PDGFRα）进行分子成像。
Nucl Med Biol. 2018 Mar;58:51-58. doi: 10.1016/j.nucmedbio.2017.12.005. Epub 2017 Dec 27.
3
Immuno-PET imaging based radioimmunotherapy in head and neck squamous cell carcinoma model.基于免疫正电子发射断层扫描成像的头颈鳞状细胞癌模型放射免疫治疗
Oncotarget. 2017 Sep 8;8(54):92090-92105. doi: 10.18632/oncotarget.20760. eCollection 2017 Nov 3.
4
Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy.18F-FDG PET/CT在接受131碘经验性治疗的分化型甲状腺癌患者中的预后作用
Medicine (Baltimore). 2017 Oct;96(42):e8344. doi: 10.1097/MD.0000000000008344.
5
PSMA Expression in Multinodular Thyroid Neoplasm on Simultaneous Ga-68-PSMA PET/MRI.镓-68-PSMA PET/MRI同步检查时多结节性甲状腺肿瘤中的PSMA表达
Indian J Nucl Med. 2017 Apr-Jun;32(2):159-161. doi: 10.4103/0972-3919.202248.
6
Utility of I-124 PET/CT in identifying radioiodine avid lesions in differentiated thyroid cancer: a systematic review and meta-analysis.I-124 PET/CT在鉴别分化型甲状腺癌中放射性碘摄取性病变方面的应用：一项系统评价和荟萃分析
Clin Endocrinol (Oxf). 2017 May;86(5):645-651. doi: 10.1111/cen.13306. Epub 2017 Feb 28.
7
Enhanced identification and functional protective role of carbon nanoparticles on parathyroid in thyroid cancer surgery: A retrospective Chinese population study.碳纳米颗粒在甲状腺癌手术中对甲状旁腺的增强识别及功能保护作用：一项中国人群回顾性研究
Medicine (Baltimore). 2016 Nov;95(46):e5148. doi: 10.1097/MD.0000000000005148.
8
Impact of combined FDG-PET/CT and MRI on the detection of local recurrence and nodal metastases in thyroid cancer.18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（FDG-PET/CT）与磁共振成像（MRI）联合应用对甲状腺癌局部复发及淋巴结转移检测的影响
Cancer Imaging. 2016 Nov 3;16(1):37. doi: 10.1186/s40644-016-0096-y.
9
Potential role of carbon nanoparticles in protection of parathyroid glands in patients with papillary thyroid cancer.碳纳米颗粒在甲状腺乳头状癌患者甲状旁腺保护中的潜在作用。
Medicine (Baltimore). 2016 Oct;95(42):e5002. doi: 10.1097/MD.0000000000005002.
10
Cancer stem cells as a potential therapeutic target in thyroid carcinoma.癌症干细胞作为甲状腺癌潜在的治疗靶点
Oncol Lett. 2016 Oct;12(4):2254-2260. doi: 10.3892/ol.2016.4936. Epub 2016 Aug 2.
Zotero 插件